|
1
|
Duncan JS, Sander JW, Sisodiya SM and
Walker MC: Adult epilepsy. Lancet. 367:1087–1100. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang T, Kong B, Gu JW, Kuang YQ, Cheng L,
Yang WT, Cheng JM, Ma Y and Yang XK: Anticonvulsant and sedative
effects of paederosidic acid isolated from Paederia scandens
(Lour.) Merrill. in mice and rats. Pharmacol Biochem Behav.
111:97–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prilipko L, deBoer MH, Dua T and Bertolote
J: Epilepsy care-The WHO/ILAE/IBE global campaign against epilepsy.
US Neurological Disease. 39–40. 2006.
|
|
4
|
Motamedi G and Meador K: Epilepsy and
cognition. Epilepsy Behav. 4:25–38. 2003. View Article : Google Scholar
|
|
5
|
Hao F, Jia LH, Li XW, Zhang YR and Liu XW:
Garcinol upregulates GABAA and GAD65 expression,
modulates BDNF-TrkB pathway to reduce seizures in
pentylenetetrazole (PTZ)-induced epilepsy. Med Sci Monit.
22:4415–4425. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rahmati B, Khalili M, Roghani M and
Ahghari P: Anti-epileptogenic and antioxidant effect of Lavandula
officinalis aerial part extract against pentylenetetrazol-induced
kindling in male mice. J Ethnopharmacol. 148:152–157. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Elger CE, Helmstaedter C and Kurthen M:
Chronic epilepsy and cognition. Lancet Neurol. 3:663–672. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmitz B: Effects of antiepileptic drugs
on mood and behavior. Epilepsia. 47:28–33. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie T, Wang WP, Jia LJ, Mao ZF, Qu ZZ,
Luan SQ and Kan MC: Effects of epigallocatechin-3-gallate on
pentylenetetrazole-induced kindling, cognitive impairment and
oxidative stress in rats. Neurosci Lett. 516:237–241. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ross JA and Kasum CM: Dietary flavonoids:
Bioavailability, metabolic effects, and safety. Ann Rev Nutr.
22:19–34. 2002. View Article : Google Scholar
|
|
11
|
Shimosaki S, Tsurunaga Y, Itamura H and
Nakamura M: Anti-allergic effect of the flavonoid myricitrin from
Myrica rubra leaf extracts in vitro and in
vivo. Nat Prod Res. 25:374–380. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim HH, Kim DH, Kim MH, Oh MH, Kim SR,
Park KJ and Lee MW: Flavonoid constituents in the leaves of
Myrica rubra sieb. et zucc. with anti-inflammatory activity.
Arch Pharm Res. 36:1533–1540. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guitard R, Paul JF, Nardello-Rataj V and
Aubry JM: Myricetin, rosmarinic and carnosic acids as superior
natural antioxidant alternatives to α-tocopherol for the
preservation of omega-3 oils. Food Chem. 213:284–295. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pan H, Hu Q, Wang J, Liu Z, Wu D, Lu W and
Huang J: Myricetin is a novel inhibitor of human inosine
5′-monophosphate dehydrogenase with anti-leukemia activity. Biochem
Biophys Res Commun. 477:915–922. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang G, Wang JJ, Tang XJ, Du L and Li F:
In vitro and in vivo evaluation of functionalized chitosan-Pluronic
micelles loaded with myricetin on glioblastoma cancer.
Nanomedicine. 12:1263–1278. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hassan SM, Khalaf MM, Sadek SA and
Abo-Youssef AM: Protective effects of apigenin and myricetin
against cisplatin-induced nephrotoxicity in mice. Pharm Biol.
55:766–774. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cho BO, Yin HH, Park SH, Byun EB, Ha HY
and Jang SI: Anti-inflammatory activity of myricetin from Diospyros
lotus through suppression of NF-κB and STAT1 activation and
Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated
RAW264.7 macrophages. Biosci Biotechnol Biochem. 80:1520–1530.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang EJ and Reichardt LF: Neurotrophins:
Roles in neuronal development and function. Annu Rev Neurosci.
24:677–736. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Binder DK, Croll SD, Gall CM and Scharfman
HE: BDNF and epilepsy: Too much of a good thing? Trends Neurosci.
24:47–53. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Papaleo F, Silverman JL, Aney J, Tian Q,
Barkan CL, Chadman KK and Crawley JN: Working memory deficits,
increased anxiety-like traits, and seizure susceptibility in BDNF
overexpressing mice. Learn Mem. 18:534–544. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Elmér E, Kokaia Z, Kokaia M, Carnahan J,
Nawa H and Lindvall O: Dynamic changes of brain-derived
neurotrophic factor protein levels in the rat forebrain after
single and recurring kindling-induced seizures. Neurosci.
83:351–362. 1998. View Article : Google Scholar
|
|
22
|
Scharfman HE, Goodman JH, Sollas AL and
Croll SD: Spontaneous limbic seizures after intrahippocampal
infusion of brain-derived neurotrophic factor. Exp Neurol.
174:201–214. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kafitz KW, Rose CR, Thoenen H and Konnerth
A: Neurotrophin evoked rapid excitation through TrkB receptors.
Nature. 401:918–921. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suzdak PD and Jansen JA: A review of the
preclinical pharmacology of tiagabine: A potent and selective
anticonvulsant GABA uptake inhibitor. Epilepsia. 36:612–626. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vianello M, Tavolato B and Giometto B:
Glutamic acid decarboxylase autoantibodies and neurological
disorders. Neurol Sci. 23:145–151. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ha JH, Lee DU, Lee JT, Kim JS, Yong CS,
Kim JA, Ha JS and Huh K: 4-Hydroxybenzaldehyde from Gastrodia elata
B1 is active in the antioxidation and GABAergic neuromodulation of
the rat brain. J Ethnopharmacol. 73:329–333. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiang J and Jiang Y: Antiepileptic
potential of matrine via regulation the levels of
gamma-aminobutyric acid and glutamic acid in the brain. Int J Mol
Sci. 14:23751–23761. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yong VW: Metalloproteinases: Mediators of
pathology and regeneration in CNS. Nat Neurosci. 6:931–944. 2005.
View Article : Google Scholar
|
|
29
|
Rivera S, Khrestchatisky M, Kaczmarek L,
Rosenberg GA and Jaworski DM: Metzincin proteases and their
inhibitors, foes or friends in nervous system physiology? J
Neurosci. 30:15337–15357. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wilczynski GM, Konopacki FA, Wilczek E,
Lasiecka Z, Gorlewicz A, Michaluk P, Wawrzyniak M, Malinowska M,
Okulski P, Kolodziej LR, et al: Important role of matrix
metalloproteinase-9 in epileptogenesis. J Cell Biol. 180:1021–1035.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang JW, Deb S and Gottschall PE:
Regional and age-related expression of gelatinases in the brains of
young and old rats after treatment with kainic acid. Neurosci Lett.
295:9–12. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim GW, Kim HJ, Cho KJ, Kim HW, Cho YJ and
Lee BI: The role of MMP-9 in integrin-mediated hippocampal cell
death after pilocarpine-induced status epilepticus. Neurobiol Dis.
36:169–180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Szklarczyk A, Lapinska J, Rylski M, McKay
RD and Kaczmarek L: Matrix metalloproteinase-9 undergoes expression
and activation during dendritic remodeling in adult hippocampus. J
Neurosci. 22:920–930. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Garber JC: (Chair): Committee for the
Update of the Guide for the Care and Use of Laboratory Animals.
Guide for the Care and Use of Laboratory Animals, eighth ed.
Washington, DC, USA: National Academy of Sciences; 2011
|
|
35
|
Wang J: The evolving regulatory
environment. International Animal Research Regulations: Impact on
neuroscience research-workshop summary. Pankevich DE, Wizemann TM,
Mazza A and Altevogt BM: The National Academies Press; Washington,
DC: pp. 13–16. 2012
|
|
36
|
The National People's Congress of China, .
Animal Husbandry Law of the People's Republic of China 2005.
Adopted at the 19th Meeting of the Standing Committee of the Tenth
National People's Congress on December 29, 2005. http://english.agri.gov.cn/governmentaffairs/lr/ap/201305/t20130508_19602.htmMay
8–2013
|
|
37
|
Löscher W: Animal models of epilepsy for
the development of antiepileptogenic and disease-modifying drugs. A
comparison of the pharmacology of kindling and post-status
epilepticus models of temporal lobe epilepsy. Epilepsy Res.
50:105–123. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bertram E: The relevance of kindling for
human epilepsy. Epilepsia. 48 Suppl 2:S65–S74. 2007. View Article : Google Scholar
|
|
39
|
Racine RJ: Modification of seizure
activity by electrical stimulation. II. Motor seizure.
Electroencephalogr Clin Neurophysiol. 32:281–294. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hui L, Pei DS, Zhang QG, Guan QH and Zhang
GY: The neuroprotection of insulin on ischemic brain injury in rat
hippocampus through negative regulation of JNK signaling pathway by
PI3 K/Akt activation. Brain Res. 1052:1–9. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, Liang G, Wang S, Meng Q, Wang Q and
Wei H: Effects of fetal exposure to isoflurane on postnatal memory
and learning in rats. Neuropharmacology. 53:942–950. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Monge-Acuña AA and Fornaguera-Trías J: A
high performance liquid chromatography method with electrochemical
detection of gamma-aminobutyric acid, glutamate and glutamine in
rat brain homogenates. J Neurosci Methods. 183:176–181. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mizoguchi H, Nakade J, Tachibana M, Ibi D,
Someya E, Koike H, Kamei H, Nabeshima T, Itohara S, Takuma K, et
al: Matrix metalloproteinase-9 contributes to kindled seizure
development in pentylenetetrazole-treated mice by converting
pro-BDNF to mature BDNF in the hippocampus. J Neurosci.
31:12963–12971. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lähteinen S, Pitkänen A, Saarelainen T,
Nissinen J, Koponen E and Castrén E: Decreased BDNF signaling in
transgenic mice reduces epileptogenesis. Eur J Neurosci.
15:721–734. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhu WJ and Roper SN: Brain-derived
neurotrophic factor enhances fast excitatory synaptic transmission
in human epileptic dentate gyrus. Ann Neurol. 50:188–194. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hoehna Y, Uckermann O, Luksch H, Stefovska
V, Marzahn J, Theil M, Gorkiewicz T, Gawlak M, Wilczynski GM,
Kaczmarek L and Ikonomidou C: Matrix metalloproteinase 9 regulates
cell death following pilocarpine-induced seizures in the developing
brain. Neurobiol Dis. 48:339–347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Schmidt D and Rogawski MA: New strategies
for the identification of drugs to prevent the development or
progression of epilepsy. Epilepsy Res. 50:71–78. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fatih S, Faruk B, Acar MD and Cafer M:
Influence of carbenoxolone on the anticonvulsant efficacy of
phenytoin in pentylenetetrazole kindled rats. Acta Neurobiol Exp
(Wars). 72:177–184. 2012.PubMed/NCBI
|
|
49
|
He XP, Wen R and McNamara JO: Impairment
of kindling development in phospholipase Cγ1 heterozygous mice.
Epilepsia. 55:456–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu X, Liu J, Liu J, Liu XL, Jin LY, Fan
W, Ding J, Peng LC, Wang Y and Wang X: BDNF-TrkB signaling pathway
is involved in pentylenetetrazole-evoked progression of
epileptiform activity in hippocampal neurons in anesthetized rats.
Neurosci Bull. 29:565–575. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mortazavi F, Ericson M, Story D, Hulce VD
and Dunbar GL: Spatial learning deficits and emotional impairments
in pentylenetetrazole-kindled rats. Epilepsy Behav. 7:629–638.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pitkänen A, Schwartzkroin PA and Moshe SL:
Models of seizures and epilepsy. (Burlington, VT). Elsevier
Academic Press, Elsevier Inc. 345–346. 2006.
|
|
53
|
Pavlova T, Stepanichev M and Gulyaeva N:
Pentylenetetrazole kindling induces neuronal cyclin B1 expression
in rat hippocampus. Neurosci Lett. 392:154–158. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Scharfman HE: Epilepsy as an example of
neural plasticity. Neuroscientist. 8:154–173. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Diemer NH, Jørgensen MB, Johansen FF,
Sheardown M and Honoré T: Protection against ischemic hippocampal
CA1 damage in the rat with a new non-NMDA antagonist NBQX. Acta
Neurol Scand. 86:45–49. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yamada K and Nabeshima T: Brain-derived
neurotrophic factor/TrkB signaling in memory processes. J Pharmacol
Sci. 91:267–270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Tanaka T, Saito H and Matsuki N:
Inhibition of GABAA synaptic responses by brain-derived
neurotrophic factor (BDNF) in rat hippocampus. J Neurosci.
17:2959–2966. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Svenningsen AB, Madsen KD, Liljefors T,
Stafford GI, Stafford GI, van Staden J and Jäeger AK: Biflavones
from Rhus species with affinity for the
GABAA/benzodiazepine receptor. J Ethnopharmacol.
103:276–80. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ren LX, Wu YL, Luo YF, Li X and Zuo DY:
Effects of amiloride on behavior and extracellular glutamate level
of frontal cortex in acute epileptic mice induced by penicillin.
Chin Pharmacol Bull. 22:1274–1275. 2006.(In Chinese).
|
|
60
|
Tian FF, Xie GJ, Yang QD, Chen ZC and Lv
BQ: Relationship between the epileptic seizure and both the GABA
concentration, and GAD activity in temporal tissue. Clin J Neurol.
33:224–226. 2000.(In Chinese).
|
|
61
|
Yang DB, Wang L, Huang M, Yu JM, Wang XM
and Luo JM: Effects of pretreatment with repetitive transcranial
magnetic stimulation on development of seizures induced by
pilocarpine and expression of GAD65 in rat hippocampus. Chin J Clin
Neurosci. 17:337–340. 2009.
|
|
62
|
Liu X, Qi ZG and Xie P: Transplantation of
GAD65-engineered neural stem cells for treatment of epilepsy: A
study in rat model. Laser J. 32:54–56. 2011.
|
|
63
|
Bazyan AS, Zhulin VV, Karpova MN, Klishina
NY and Glebov RN: Long-term reduction of benzodiazepine receptor
density in the rat cerebellum by acute seizures and kindling and
its recovery 6 months later by a pentylenetetrazole challenge.
Brain Res. 888:212–220. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Armijo JA, de las Cuevas I and Adín J: Ion
channels and epilepsy. Rev Neurol. 30 (Suppl 1):S25–S41. 2000.(In
Spanish). PubMed/NCBI
|
|
65
|
Sharma AK, Reams RY, Jordan WH, Miller MA,
Thacker HL and Snyder PW: Mesial temporal lobe epilepsy:
Pathogenesis, induced rodent models and lesions. Toxicol Pathol.
35:984–999. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Konopacki FA, Rylski M, Wilczek E,
Amborska R, Detka D, Kaczmarek L and Wilczynski GM: Synaptic
localization of seizure-induced matrix metalloproteinase-9 mRNA.
Neuroscience. 150:31–39. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Rylski M, Amborska R, Zybura K, Michaluk
P, Bielinska B, Konopacki FA, Wilczynski GM and Kaczmarek L: Jun-B
is a repressor of MMP-9 transcription in depolarized rat brain
neurons. Mol Cell Neurosci. 40:98–110. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Hwang JJ, Park MH, Choi SY and Koh JY:
Activation of the Trk signaling pathway by extracellular zinc. Role
of metalloproteinases. J Biol Chem. 280:11995–12001. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ethell IM and Ethell DW: Matrix
metalloproteinases in brain development and remodeling: Synaptic
functions and targets. J Neurosci Res. 85:2813–2823. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Mizoguchi H and Yamada K: Roles of matrix
metalloproteinases and their targets in epileptogenesis and
seizures. Clin Psychopharmacol Neurosci. 11:45–52. 2013. View Article : Google Scholar : PubMed/NCBI
|
